Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapy.
Zhang B, Shi J, Shi X, Xu X, Gao L, Li S, Liu M, Gao M, Jin S, Zhou J, Fan D, Wang F, Ji Z, Bian Z, Song Y, Tian W, Zheng Y, Xu L, Li W.
Zhang B, et al. Among authors: xu l, xu x.
Drug Resist Updat. 2024 May;74:101068. doi: 10.1016/j.drup.2024.101068. Epub 2024 Feb 13.
Drug Resist Updat. 2024.
PMID: 38402670